ACHL – achilles therapeutics plc - american depositary shares (US:NASDAQ)
Stock Stats
News
Achilles Therapeutics plc (NASDAQ: ACHL) had its price target lowered by analysts at Chardan Capital from $11.00 to $6.00. They now have a "buy" rating on the stock.
Achilles Therapeutics plc (NASDAQ: ACHL) was downgraded by analysts at Piper Sandler from an "overweight" rating to a "neutral" rating. They now have a $2.00 price target on the stock, down previously from $8.00.
Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights [Yahoo! Finance]
Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights
Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning [Yahoo! Finance]
Form S-8 Achilles Therapeutics
Form 20-F Achilles Therapeutics For: Dec 31
Form SC 13G/A Achilles Therapeutics Filed by: Artal International S.C.A.
Form SC 13G/A Achilles Therapeutics Filed by: BAKER BROS. ADVISORS LP
Form SC 13G/A Achilles Therapeutics Filed by: Syncona Portfolio Ltd
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.